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Functional ‘unlocking’: bedside detection of
covert awareness after severe brain damage
This scientific commentary refers to
‘Characterization of EEG signals re-
vealing covert cognition in the injured
brain’, by Curley et al. (doi:10.1093/
brain/awy070).
Severe acute brain damage, most often
caused by trauma, anoxia or stroke,
can result in coma—a transient state
characterized by complete absence of
wakefulness and of signs of awareness.
The recovery of wakefulness without
signs of awareness heralds a transition
to vegetative state/unresponsive wake-
fulness syndrome (VS/UWS). Patients
in a minimally conscious state (MCS)
show reproducible purposeful behav-
iours but remain unable to communi-
cate. MCS can be divided into MCS+
and MCS depending on the presence
or absence of inconsistent language
functions. Emergence of MCS (EMCS)
is diagnosed when patients regain
functional communication. Finally, pa-
tients with locked-in syndrome can be
misdiagnosed with these disorders of
consciousness because of complete par-
alysis of voluntary muscles, except for
eye-coded communication (Gosseries
et al., 2014). Prevalence rates of VS/
UWS and MCS are difficult to evaluate
because of a lack of systematic surveil-
lance. In the USA, prevalence estimates
range from 25 000 to 420 000 for VS/
UWS and from 112 000 to 280 000 for
MCS (Hirschberg and Giacino, 2011).
In this issue of Brain, Curley and co-
workers address the difficult problem
of detecting covert awareness in non-
communicative patients with severe
brain damage (Curley et al., 2018).
The detection of covert awareness
in patients with disorders of con-
sciousness after coma has important
consequences for diagnosis, prognosis
and therapy, including pain manage-
ment, rehabilitation and end-of-life
decisions. However, high rates of
misdiagnosis (up to 40%) have re-
peatedly been reported between VS/
UWS and MCS. At least five repeated
behavioural assessments with a vali-
dated standardized scale, the Coma
Recovery Scale-Revised (CRS-R), are
required to make an accurate clinical
diagnosis (Wannez et al., 2017). Yet
even after exhaustive behavioural
assessments are performed, signs of
covert awareness can be detected in
20% of patients in a behavioural
VS/UWS with functional MRI and
EEG command-following paradigms
(e.g. Monti et al., 2010; Cruse et al.,
2011) or with transcranial magnetic
stimulation combined with high-dens-
ity EEG (TMS-EEG) (Casarotto et al.,
2016). These findings have recently
led to the definition of a new clin-
ical entity, referred to as MCS*,
functional locked-in syndrome or cog-
nitive motor dissociation syndrome
(CMD), where patients are
behaviourally unresponsive but show
evidence of covert awareness with
neuroimaging. While the pathophysi-
ology of CMD remains unclear, the
majority of patients diagnosed so
far had sustained a traumatic brain
injury. The recognition of a high
prevalence of CMD after severe
brain damage creates an urgent
need to improve routine diagnosis of
covert awareness and to find means
to re-establish communication with
these behaviourally unresponsive but
conscious individuals. Despite consti-
tuting a significant advance, func-
tional MRI command-following
paradigms are challenging to use in
routine clinical practice because of
their lack of portability. Curley et al.
describe a new approach to detect
covert awareness in patients with
severe brain damage at the bedside,
using repetitive testing with EEG
command-following paradigms. The
New York team led by Nicholas
Schiff used a variety of tasks, aiming
to assess within-subject reliability of
responses while taking into account
between-subject variability in brain
physiology after brain damage. They
also performed a systematic compari-
son between EEG, behavioural data
and functional MRI command-fol-
lowing paradigms.
The new study included 28 patients
with severe acquired brain damage and
15 controls. Among these 28 patients,
17 met behavioural criteria for MCS
(one of whom also had an assessment
while behaviourally in VS/UWS), eight
for EMCS (two of whom also had an
assessment while behaviourally in
MCS) and three for VS/UWS. The au-
thors performed assessments using a
37-electrode EEG system in most sub-
jects (two patients were recorded with
23 and 29 electrodes). Mental imagery
tasks consisted of imagining playing
tennis, spatial navigation, swimming,
and/or finger tapping. Data analysis
quantified changes in EEG power
during 10–14 s silent periods following
task instructions compared to 10–14 s
silent periods following instructions to
rest. Criteria for a positive response to
command required two outcomes: first,
results had to show significance in at
least one run and a trend towards sig-
nificance in at least one other run for a
difference between task and rest in a
given channel for at least two contigu-
ous frequency bins, after a two-group
resampling test. Second, results also
had to be significant after correction
for multiple comparisons across chan-
nels using the false discovery rate for a
two-group test applied to concatenated
data from all runs of a given task. These
conservative criteria led to an estimation
of false positives of 8% in shuffled data
from the ‘tennis’ paradigm.
Evidence of EEG command-follow-
ing was found in 21/28 patients stu-
died (2/3 VS/UWS, 11/17 MCS and
all eight EMCS)—and all 15 controls.
Evidence of functional MRI response
to command was found in 9/23
patients (five EEG command-follower
patients could not undergo MRI).
This is in contrast with previous stu-
dies (Monti et al., 2010; Cruse et al.,
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2011), which documented 20% re-
sponders in VS/UWS and no evidence
of functional MRI command-follow-
ing in MCS. Curley et al.’s high re-
sponse rate using both EEG and
functional MRI could be related to
differences in task design: shorter
blocks of 10–14 s could be more sen-
sitive to detecting patient responders
with fluctuating arousal. A higher
sensitivity of EEG for detecting
covert command-following in MCS
is also in line with results of a previ-
ous EEG study assessing increases in
P300 amplitude after patients were in-
structed to voluntarily attend to their
own name (Schnakers et al., 2008).
As Curley et al. mention, their
higher rate of responders may also
be partly explained by selection bias:
included patients were able to
undergo repetitive good quality
assessments, and all except one had
EEG backgrounds that were only
mildly to moderately abnormal.
Command-following with EEG or
functional MRI is suggestive of pre-
served communication abilities, as
such paradigms have previously been
used by VS/UWS patients to accurately
answer questions with yes/no choices
(Monti et al., 2010). Importantly,
among the 21 EEG command-followers
in Curley et al. (2018), only 40%
showed communication abilities ac-
cording to the CRS-R. Assessments of
EEG command-following abilities may
provide added value to detect patients
who may be candidates for EEG-based
brain-computer interfaces, allowing
them to consciously control and inter-
act with their environment.
For most patients, EEG responses to
command were only achieved for one
of the tasks. These findings are in line
with the need for repeated behavioural
assessments to sensitively detect con-
sciousness at the bedside (Wannez
et al., 2017). Five MCS patients who
were at first categorized as non-re-
sponders in some tasks were found to
have positive responses after rejecting
trials with low vigilance at EEG base-
line. All of these patients were found to
have positive responses in other tasks.
Future studies may restrict testing
conditions to periods with sustained
EEG arousal, perhaps optimized
through EEG vigilance monitoring
coupled to arousal facilitation
procedures.
EEG responses to command in
healthy volunteers showed a consist-
ent attenuation of alpha-beta power
over central channels. Patients with
brain damage showed variable but re-
producible spatiotemporal patterns of
EEG responses, with either increased
or decreased power in delta to beta
frequencies. These differences in EEG
patterns may be partially explained
by deafferentation, with local activa-
tion reflected by decreased sleep-like
oscillations rather than by a normal
dampening of thalamocortical idle
rhythms. The authors also reported
the observation of a patient tested
twice during recovery, whose re-
sponse at first took the form of an
increase, then a decrease in alpha
power. This finding raises important
questions about neural processes tran-
scending particular brain oscillations
that may sustain consciousness and
cognition.
Although more sensitive than previ-
ous functional MRI designs, the sensi-
tivity of Curley et al.’s approach was
not perfect: six MCS subjects did not
respond to EEG tasks, one of whom
had shown intentional communication
abilities behaviourally. These findings
emphasize the complementarity of clin-
ical and neuroimaging approaches,
with clear added value of EEG com-
pared to functional MRI. In a more
general sense, clinical or motor-inde-
pendent command-following paradigms
may also miss conscious patients with
aphasia, abulia or sensory impairment
that would prevent their participation
in tasks (Boly et al., 2007). Therefore,
assessments of ‘resting state’ spontan-
eous brain activity using metabolic
PET imaging, functional MRI or EEG
provide useful complementary informa-
tion (Gosseries et al., 2014). Objective
markers of consciousness derived
from theoretical approaches—such as
TMS-EEG with the perturbational
complexity index (PCI) (Casarotto
et al., 2016)—also constitute promising
indices shown to be highly sensitive
and specific for detecting consciousness
in motor-unresponsive subjects.
Perhaps the most important contri-
butions of Curley et al. (2018) are to
pave the way for large-scale investiga-
tions on the prevalence of covert
awareness after severe brain damage,
and to show that many patients be-
haviourally in MCS may in reality
be in a state closer to a functional
locked-in syndrome rather than in a
sedated state. As the ability to com-
municate is the strongest predictor of
good quality of life in chronic locked-
in syndrome (with an odds ratio of
20) (Bruno et al., 2011), ethical prin-
ciples of both beneficence and respect
for autonomy should prompt us to
continue efforts to re-establish com-
munication with CMD subjects.
Novel technologies such as those re-
ported here by Curley et al. will even-
tually lead to a revised nosology of
post-coma states, based on objective
brain measures of residual cognition,
unbiased by motor incapacity.
Ultimately, this will enable these vul-
nerable patients to demand their right
to better rehabilitation care, self-de-
termination and quality of life.
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Is longitudinal tau PET ready for use in
Alzheimer’s disease clinical trials?
This scientific commentary refers to
‘Longitudinal tau PET in ageing and
Alzheimer’s disease’, by Jack, Jr et al.
(doi:10.1093/brain/awy059).
Tau PET imaging, using radiotracers
like 18F-flortaucipir, has been shown
to reliably detect the tau-containing
paired helical filaments typical of
Alzheimer’s disease dementia in vitro
and in vivo (Smith et al., 2016).
18F-flortaucipir may also bind to tau
aggregates in other tauopathies,
including corticobasal degeneration
and progressive supranuclear palsy,
albeit to a much lesser extent com-
pared to Alzheimer’s disease (Smith
et al., 2017). Given the central role
that accumulation of tau pathology is
thought to play in the progression and
clinical manifestation of Alzheimer’s
disease, the ability to measure this
pathology in vivo represents a major
step forward and provides opportu-
nities for early diagnosis and assess-
ment of target engagement in clinical
trials. As tau PET is a novel technol-
ogy, longitudinal studies determining
the change over time in the regional
uptake of 18F-flortaucipir have not
been available to date. In this issue
of Brain, Jack and co-workers evalu-
ate the change over 1 year in tau PET
signal in a relatively large group of
clinically unimpaired individuals with
differing amyloid-b status (59 amyl-
oid-b-negative and 37 amyloid-b-posi-
tive), as well as 30 amyloid-b-positive
individuals with mild cognitive impair-
ment or Alzheimer’s disease dementia
(Jack et al., 2018).
The results reveal significant tau ac-
cumulation in the amyloid-b-positive
clinically unimpaired group, in a
pattern that is not restricted to the
medial temporal lobe but also encom-
passes medial parietal areas, including
the posterior cingulate cortex. This
suggests that the initial accumulation
of tau aggregates in Alzheimer’s dis-
ease may not be restricted to the
medial temporal lobes as much as
implied by Braak staging. Instead,
Jack et al. demonstrate that early lon-
gitudinal tau aggregation coincides
with regions showing accumulation
of amyloid-b fibrils during the earliest
stages of preclinical Alzheimer’s
disease (Palmqvist et al., 2017).
Although there was no significant
change at the group level among
the amyloid-b-negative unimpaired
group, previous cross-sectional studies
have revealed mild associations be-
tween older age and increased reten-
tion of 18F-flortaucipir in the medial
temporal lobe (Lowe et al., 2018).
This might be congruent with a very
slow and subtle accumulation of
tau aggregates in these regions over
decades in amyloid-b-negative indi-
viduals. However, the observation
that amyloid-b positivity was the
strongest predictor of tau accumula-
tion among unimpaired individuals
reiterates that accumulation of amyl-
oid-b fibrils is an important driver for
the build-up of tau aggregates during
preclinical Alzheimer’s disease (Price
and Morris, 1999), at least to reach
the levels detectable with tau PET
imaging.
It is possible that PET imaging
with tracers like 18F-flortaucipir or
18F-florbetapir may not be able to
detect the earliest accumulation of
either tau or amyloid-b, as these tra-
cers reveal only certain aspects of the
pathology that occur later in the
disease process (Fig. 1). Specifically,
the amyloid tracers (11C-PiB and the
18F ligands) were developed from
Thioflavin-T, and measure predomin-
antly amyloid-b fibrils in cored/neur-
itic plaques, and more variably diffuse
plaques. Thus, amyloid PET imaging
techniques likely do not measure
intraneuronal accumulation of amyl-
oid-b in endosomes/multivesicular
bodies, or the intracellular as well as
extracellular amyloid-b oligomers,
which probably precede the
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